---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-020176"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2021-10-18T23:59:59+00:00"
generated_at: "2026-06-28T20:16:56.400235+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Avalo Therapeutics appoints Keith Maher, MD to Board under Armistice Capital right

## Summary
- Keith Maher, MD appointed to board effective Oct 15, 2021; term until 2022 annual meeting.
- Maher is employed by Armistice Capital Master Fund, a significant stockholder; CIO Steven J. Boyd already on board.
- Armistice participated in five offerings since Feb 2020, including 5.45M shares in Sept 2021 offering raising $29.3M net.
- Armistice purchased shares in each offering on same terms as other investors.

## SEC filing metadata
- accession: 0001628280-21-020176
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2021-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828021020176/0001628280-21-020176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828021020176/avtx-20211015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-020176
- JSON: https://secwatch.observer/filing/0001628280-21-020176.json
- Plain text: https://secwatch.observer/filing/0001628280-21-020176.txt

## Key facts
- Executive change
  Keith Maher, MD was appointed as director at Avalo Therapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: On October 15, 2021, the board of directors (the “ Board ”) of Avalo Therapeutics, Inc. (the “ Company ”) appointed Keith Maher, MD, to the Board, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534120/000162828021020176/0001628280-21-020176-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.